Study on gene therapy using non-viral vector for joint disease

非病毒载体治疗关节疾病的基因治疗研究

基本信息

  • 批准号:
    11470314
  • 负责人:
  • 金额:
    $ 9.41万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

Usefulness of three types of cationic polymer, i.e., degraded polyamidoamine (PAMAM) dendrimer (SuperFect Transfection Reagent), linear polyethylenimine (PEI) (ExGen 500) and branched PEI in gene delivery into chondrocytes was comparatively examined. A plasmid vector containing the E.coli LacZ (pSES.β) was combined with one of the three cationic polymers at various molar ratios and the resultant complex (polyplex) was used to transduce a human chondrocyte-like cell line, HCS-2/8. Gene expression was evaluated by the O-Nitrophenyl β-D-Galactopyranoside (ONPG) assay and X-gal staining. The ONPG assay showed that the highest delivery rate was achieved when 2 μg of pSES.β was combined with either 21 μg of dendrimer, 1.7 μg of linear PEI, or 2.0 μg of branched PEI.At the same DNA/polymer ratios, the proportions of X-gal-staining cells were also the highest (31, 30, and 8%, respectively). LacZ expression reached the highest level 3days after the dendrimer-mediated transduction, gradually declined and returned to the background level on day 14. Possible cytotoxicity was examined by trypan blue staining and phase contrast microscopic observations. Neither cytotoxicity nor morphological change was induced at the optimal dose of each polymer. The cationic polymers, particularly the degraded dendrimer and linear PEI, would be a useful non-viral vector for gene delivery to the cells in chondrocyte lineage.
三种类型的阳离子聚合物,即,降解的聚酰胺胺(PAMAM)树状聚合物(SuperFect Transfection Reagent)、线性聚乙烯亚胺(PEI)(ExGen 500)和支化PEI在基因递送到软骨细胞中的作用进行了比较研究。将含有大肠杆菌LacZ(pSES.β)的质粒载体与三种阳离子聚合物中的一种以各种摩尔比组合,并将所得复合物(多聚物)用于培养人软骨细胞样细胞系HCS-2/8。通过邻硝基苯基β-D-吡喃半乳糖苷(ONPG)测定和X-gal染色评估基因表达。ONPG检测显示,当2 μg pSES.β与21 μg树枝状聚合物、1.7 μg线性PEI或2.0 μg支化PEI组合时,获得最高的递送率。在相同的DNA/聚合物比例下,X-gal染色细胞的比例也最高(分别为31、30和8%)。LacZ表达在转染后3d达到最高水平,随后逐渐下降,并在第14天恢复到背景水平。通过台盼蓝染色和相差显微镜观察检查可能的细胞毒性。在每种聚合物的最佳剂量下,均未诱导细胞毒性或形态学变化。阳离子聚合物,特别是降解的树枝状聚合物和线性PEI,将是一个有用的非病毒载体的基因传递到软骨细胞系的细胞。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
久保俊一, 他: "関節疾患に対する非ウイルスベクターを用いた遺伝子導入法"整形外科. 51. 839-845 (2000)
Shunichi Kubo 等:“使用非病毒载体治疗关节疾病的基因转移方法”Orthopedics 51. 839-845 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S.Ohashi: "Cationic polymer-mediated genetic transduction into cultured human chondrosarcoma-derived HCS-2/8 Cells."Journal of Orthopaedic Science. 6. 75-81 (2001)
S.Ohashi:“阳离子聚合物介导的基因转导到培养的人软骨肉瘤衍生的 HCS-2/8 细胞中。”骨科科学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S.Ohashi et al.: "cationic polymer-mediated genetic transduction into cultured human chondrosarcoma-derived HCS-2/8 cells"Journal of Orthopaedic Science. 6. 75-81 (2001)
S.Ohashi 等人:“阳离子聚合物介导的遗传转导进入培养的人软骨肉瘤来源的 HCS-2/8 细胞”《骨科科学杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KUBO Toshikazu其他文献

KUBO Toshikazu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KUBO Toshikazu', 18)}}的其他基金

The analysis of thermotherapy combined with drugs for osteoarthritis
热疗联合药物治疗骨关节炎的分析
  • 批准号:
    23650333
  • 财政年份:
    2011
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
The analysis of cellular stress response towards novel conservative therapies for joint disease
关节疾病新型保守疗法的细胞应激反应分析
  • 批准号:
    20390404
  • 财政年份:
    2008
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
development of novel conservative therapies for joint disease under controlled HSP expression-usage of HSP-inducing agents and thermotherapy-
开发针对受控 HSP 表达的关节疾病的新型保守疗法 - 使用 HSP 诱导剂和热疗 -
  • 批准号:
    17390419
  • 财政年份:
    2005
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mechanical response of chondrocyte under intermittent hydrostatic pressure loading.-Regeneration of Articular Cartilage
间歇静水压负荷下软骨细胞的机械反应-关节软骨的再生
  • 批准号:
    15390464
  • 财政年份:
    2003
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Establishment of gene analytic method to prevent the development of the steroid induced osteonecrosis of the femoral head.
建立基因分析方法以预防类固醇引起的股骨头坏死的发生。
  • 批准号:
    13470314
  • 财政年份:
    2001
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Control of synovitis using gene therapy.
使用基因疗法控制滑膜炎。
  • 批准号:
    12557127
  • 财政年份:
    2000
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Basic Research of Gene Therapy for Joint Diseases
关节疾病基因治疗基础研究
  • 批准号:
    09470320
  • 财政年份:
    1997
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Expression and role of stress protein at the injury of joint cartilage
应激蛋白在关节软骨损伤中的表达及作用
  • 批准号:
    05454411
  • 财政年份:
    1993
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Development of non-viral vector to realize treatment of hereditary disease using genome editing RNA technology
开发非病毒载体,利用基因组编辑RNA技术实现遗传性疾病的治疗
  • 批准号:
    19K22972
  • 财政年份:
    2019
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Development of a non-viral vector to realize hereditary intractable disease treatment using genome editing technology
利用基因组编辑技术开发非病毒载体实现遗传性疑难病治疗
  • 批准号:
    16K15322
  • 财政年份:
    2016
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of non-viral vector for gene therapy strategy using iPS cells
使用 iPS 细胞开发用于基因治疗策略的非病毒载体
  • 批准号:
    22890088
  • 财政年份:
    2010
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
The Role of Cell Membrane Disruption in Non-Viral Vector Oligonucleotide Delivery
细胞膜破坏在非病毒载体寡核苷酸递送中的作用
  • 批准号:
    8281534
  • 财政年份:
    2006
  • 资助金额:
    $ 9.41万
  • 项目类别:
The Role of Cell Membrane Disruption in Non-Viral Vector Oligonucleotide Delivery
细胞膜破坏在非病毒载体寡核苷酸递送中的作用
  • 批准号:
    8473070
  • 财政年份:
    2006
  • 资助金额:
    $ 9.41万
  • 项目类别:
The Role of Cell Membrane Disruption in Non-Viral Vector Oligonucleotide Delivery
细胞膜破坏在非病毒载体寡核苷酸递送中的作用
  • 批准号:
    8128427
  • 财政年份:
    2006
  • 资助金额:
    $ 9.41万
  • 项目类别:
The Role of Cell Membrane Disruption in Non-Viral Vector Oligonucleotide Delivery
细胞膜破坏在非病毒载体寡核苷酸递送中的作用
  • 批准号:
    7985421
  • 财政年份:
    2006
  • 资助金额:
    $ 9.41万
  • 项目类别:
Brain protection and recirculation therapy with non-viral vector gene
非病毒载体基因的脑保护和再循环治疗
  • 批准号:
    14370432
  • 财政年份:
    2002
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了